Platelet Activation Induced by a Stable Analogue of Endoperoxides (U46619)

• References

• 1 di Minno G, Bertelé V, Bianchi L, Barbieri B, Cerletti C, Dejana E, de Gaetano G, Silver MJ. Effects of an epoxymethano stable analogue of prostaglandin endoperoxides (U46619) on human platelets. Thromb Haemostas 1981; 45: 103-106
• 2 Cerletti C, Minoldo S, Bucchi F, Del Maschio A, de Gaetano G. Requirement of ADP for arachidonic acid-induced platelet aggregation: studies with selective thromboxane-synthase inhibitors. Biochem Pharmacol 1986; 35: 1201-1203
• 3 Prosdocimi M, Zatta A, Gorio A, Zanetti A, Dejana E. Action of AD₆(8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmethoxy coumarin) on human platelets in vitro. Naunyn-Schmiedeberg’s Arch Pharmacol 1986; 332: 305-310
• 4 Morinelli TA, Niewiarowski S, Kornecki E, Figures WR, Wachtfogel Y, Colman RW. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues. Blood 1983; 61: 41-49
• 5 Morinelli TA, Niewiarowski S, Daniel JL, Smith JB. Receptor- mediated effects of a PGH₂ analogue (U46619)on human platelets. Am J Physiol 1987; 253: H1035-H1043
• 6 Parise LV, Venton DL, Le Breton GC. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A₂/prostaglandin H₂receptor interaction. J Pharmacol Exp Ther 1984; 228: 240-244
• 7 Bennet JS, Vilaire G, Burch JW. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors. J Clin Invest 1981; 68: 981-987
• 8 Ingerman CM, Smith JB, Shapiro S, Sedar A, Silver MJ. Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. Blood 1978; 52: 332-344